Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
The trial is the first to test a hydrogel designed to repair cardiac tissue. It is also the first to test a hydrogel made from the natural scaffolding of cardiac muscle tissue, also known as extracellular matrix, or ECM. This is significant because ECM hydrogels have been shown in preclinical studies to potentially be effective for other conditions, such as poor blood circulation due to peripheral artery disease. The trial showed that the hydrogel, known as VentriGel, can be safely injected via catheter into patients who had suffered a heart attack in the past 2 to 36 months.
“Although the study was designed to evaluate safety and feasibility and not designed to show whether VentriGel effectively helps improve heart function, we observed some improvements in patients,” said Karen Christman, the paper’s senior author and a professor of bioengineering in the Jacobs School of Engineering and the Institute of Engineering in Medicine at UC San Diego. “For example, patients could walk longer distances. We also observed signs of improving heart function in patients who experienced a heart attack more than one year prior to treatment.”
Researchers from Ventrix, led by Christman, report their findings in the Sept. 11 issue of the Journal of the American College of Cardiology: Basic to Translational Science. Dr. Jay Traverse from the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital was the lead clinical investigator.
There are an estimated 785,000 new heart attack cases in the United States each year, with no established treatment for repairing the resulting damage to cardiac tissue. After a heart attack, scar tissue develops, which diminishes muscle function and leads to heart failure. This is where VentriGel comes in. Once injected in damaged cardiac muscle, VentriGel forms a scaffold that acts as a reparative environment where healthy cells migrate, leading to increases in cardiac muscle, less scar tissue, and improvements in heart function.
VentriGel was invented by Christman and her team, then licensed from UC San Diego and developed by Ventrix, Inc, which was cofounded by CEO Adam Kinsey and Christman.
VentriGel is made from cardiac connective tissue taken from pigs, which is stripped of heart muscle cells through a cleansing process. It is then freeze-dried and milled into powder form, and then liquefied into a fluid that can be easily injected into heart muscle in a minimally invasive procedure that does not require surgery. Once it hits body temperature, the liquid turns into a semi-solid, porous gel.
The Phase 1 trial evaluated the gel in 15 patients who sustained moderate damage in the left ventricle chamber of the heart following a heart attack. Each patient received up to 18 injections of VentriGel into the damaged region via catheter. Researchers followed the patients for six months after treatment. All patients completed the full follow-up.
Twelve of the 15 patients were men. All 15 were experiencing mild to moderate heart failure following a heart attack. Half had suffered a heart attack within the past year.
Patients took a six-minute walking test as well as a heart function assessment and a heart health questionnaire before the injections. They retook the tests three and six months later. In addition, patients underwent an MRI at three and six months after the procedures.
Ventrix is now gearing up for a Phase 2 clinical trial that will expand on this successful first-in-human study. They are planning a larger, randomized trial that will evaluate how effectively VentriGel can improve cardiac function and quality of life for patients experiencing heart failure.
The Latest on: Heart repair
via Google News
The Latest on: Heart repair
- Transcatheter heart valve replacement market to grow by 12% over the next 10 years, report sayson August 8, 2022 at 11:12 am
The transcatheter heart valve replacement market is expected to grow at a compound annual growth rate of 12 percent from 2022 to 2032, according to a new report from consulting firm FMI. The report ...
- New Intensive Cardiac Rehab Program at Modern Heart and Vascular Instituteon August 8, 2022 at 7:00 am
Modern Heart and Vascular Institute is proud to offer an intensive cardiac rehabilitation program designed to help patients get back to their normal lives after being diagnosed with cardiovascular ...
- Novel Drug Shows Potential to Repair Stroke Damageon August 8, 2022 at 4:55 am
The only current FDA-approved drug for treatment of stroke does not repair damage and must be administered within 4.5 hours of stroke onset. When a stroke happens, lack of blood flow to the brain ...
- Blood substitute repairs damaged organs hours after heart stopson August 5, 2022 at 2:31 am
Use of an artificial blood substitute can reverse cell damage caused by lack of oxygen and could make more organs available for transplants, treat heart attacks and strokes and even reverse death ...
- Toyota Has a Change of Heart, Covers Warranty Repair for Blown GR86 Engineon August 4, 2022 at 10:00 am
The warranty claim for Blake Alvarado's GR86, which suffered a spun bearing while autocrossing, will be honored.
- Boy born with congenital heart defect called Swiss cheese heart is thriving after surgeryon August 4, 2022 at 6:34 am
Maverick Waler's parents thought he'd need multiple surgeries or even a heart transplant because of his Swiss cheese heart. Until they met Dr. Emile Bacha.
- Premature menopause is associated with increased risk of heart problemson August 3, 2022 at 4:10 pm
Menopause before 40 years of age is associated with elevated risks of heart failure and atrial fibrillation, according to a study published today in European Heart Journal, a journal of the European ...
- From Doctor to Terrorist; Do Women Really Live Longer? Heart Damage After COVIDon August 3, 2022 at 6:32 am
New research called into question the long-held belief that women outlive men. ( BMJ Open) In an 86-11 vote, the Senate passed legislation to expand healthcare benefits for millions of military ...
- Sleeping and heart health: Best sleeping positionson August 3, 2022 at 3:15 am
A recent study out of Harvard finds people in midlife who have a combination of sleep problems, like waking up in the early hours, or sleeping less than six hours ...
- Zebrafish Can Repair a Damaged Heart, And a New Study Reveals Howon July 26, 2022 at 12:40 am
Zebrafish are marvelous creatures. Not only are they completely see-through, but they can also grow new organs. We already knew these translucent little fish could regenerate retinal tissue in their e ...
via Bing News